Soken Chemical & Engineering Co., Ltd.
Soken Chemical & Engineering Co., Ltd. (4972.T) Financial Performance & Income Statement Overview
Analyze Soken Chemical & Engineering Co., Ltd. (4972.T) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Soken Chemical & Engineering Co., Ltd. (4972.T) Income Statement & Financial Overview
Review Soken Chemical & Engineering Co., Ltd. 4972.T income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $12.43B | $10.87B | $12.67B | $11.66B |
| Cost of Revenue | $8.42B | $7.42B | $8.26B | $7.76B |
| Gross Profit | $4.01B | $3.46B | $4.41B | $3.89B |
| Gross Profit Ratio | $0.32 | $0.32 | $0.35 | $0.33 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $2.67B | $2.25B | $2.36B | $2.16B |
| Operating Expenses | $2.67B | $2.24B | $2.36B | $2.16B |
| Total Costs & Expenses | $11.09B | $9.66B | $10.62B | $9.92B |
| Interest Income | $26.13M | $17.30M | $23.18M | $21.67M |
| Interest Expense | $45.31M | $27.75M | $33.89M | $26.86M |
| Depreciation & Amortization | $682.34M | $559.50M | $619.79M | $561.71M |
| EBITDA | $1.92B | $1.77B | $2.43B | $2.39B |
| EBITDA Ratio | $0.15 | $0.16 | $0.19 | $0.21 |
| Operating Income | $1.34B | $1.21B | $2.06B | $1.74B |
| Operating Income Ratio | $0.11 | $0.11 | $0.16 | $0.15 |
| Other Income/Expenses (Net) | -$154.39M | $180.00M | -$276.00M | $64.00M |
| Income Before Tax | $1.19B | $1.39B | $1.78B | $1.80B |
| Income Before Tax Ratio | $0.10 | $0.13 | $0.14 | $0.15 |
| Income Tax Expense | $765.63M | $241.00M | $429.61M | $346.00M |
| Net Income | $422.13M | $1.15B | $1.35B | $1.46B |
| Net Income Ratio | $0.03 | $0.11 | $0.11 | $0.12 |
| EPS | $25.44 | $138.95 | $162.85 | $175.69 |
| Diluted EPS | $25.44 | $138.95 | $162.85 | $175.69 |
| Weighted Avg Shares Outstanding | $16.57M | $8.29M | $8.29M | $8.28M |
| Weighted Avg Shares Outstanding (Diluted) | $16.57M | $8.29M | $8.29M | $8.28M |
Over the past four quarters, Soken Chemical & Engineering Co., Ltd. demonstrated steady revenue growth, increasing from $11.66B in Q1 2024 to $12.43B in Q4 2024. Operating income reached $1.34B in Q4 2024, maintaining a consistent 11% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $1.92B, reflecting operational efficiency. Net income dropped to $422.13M, with EPS at $25.44. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan